Brain1
Brainwave Entrainment Device
Health Tech & Life Sciences
Non Active, Jan 2026 ceased to operate
Company Overview
Snapshot
Founded in December 2015 by Avi Weinberger, Brain1 operates with 1–10 employees. The company has raised $800,000 across one funding round from one investor. Brain1 ceased operations in January 2026.
Business overview
Brain1 develops BrainWavez, a consumer device utilizing brainwave entrainment technology to enhance user well-being. The technology, informed by extensive research, aims to improve focus, boost energy, reduce stress, facilitate sleep, and address symptoms of Alzheimer’s disease through 40 Hz light therapy. The company operates within the Health Tech & Life Sciences sector, specifically targeting digital healthcare, digital therapeutics, and medical devices markets.
Log in to access full profile ›Company Intelligence Q&A
- What is Brain1's primary product?
- Brain1's primary product is BrainWavez, a consumer device that uses brainwave entrainment technology to improve various aspects of users' quality of life.
- When was Brain1 founded?
- Brain1 was founded in December 2015 by Avi Weinberger.
- What is the status of Brain1?
- Brain1 is currently non-active, having ceased operations in January 2026.
- What is the total funding raised by Brain1?
- Brain1 raised a total of $800,000 in January 2018 across one funding round.
- What markets does Brain1 target?
- Brain1 targets geomarkets including the United States, Europe, Asia, and North America with its brainwave entrainment technology.